Orphan drugs: understanding the rare disease market and its dynamics
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Oxford [u.a.]
WP, Woodhead Publ.
2013
|
| Series: | Woodhead publishing series in biomedicine
46 |
| Subjects: | |
| Item Description: | Literaturangaben und Index |
| Physical Description: | XVIII, 317 S. graph. Darst. |
| ISBN: | 9781907568091 1907568093 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV042096295 | ||
| 003 | DE-604 | ||
| 005 | 20150210 | ||
| 007 | t | ||
| 008 | 140929s2013 d||| |||| 00||| eng d | ||
| 020 | |a 9781907568091 |9 978-1-907568-09-1 | ||
| 020 | |a 1907568093 |9 1-907568-09-3 | ||
| 035 | |a (DE-599)BVBBV042096295 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 | ||
| 100 | 1 | |a Hernberg-Ståhl, Elizabeth |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Orphan drugs |b understanding the rare disease market and its dynamics |c Elizabeth Hernberg-Ståhl and Miroslav Reljanović |
| 264 | 1 | |a Oxford [u.a.] |b WP, Woodhead Publ. |c 2013 | |
| 300 | |a XVIII, 317 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Woodhead publishing series in biomedicine |v 46 | |
| 500 | |a Literaturangaben und Index | ||
| 650 | 4 | |a Orphan drugs / Law and legislation / United States | |
| 650 | 4 | |a Drug approval / United States | |
| 650 | 4 | |a Orphan Drug Production / United States | |
| 650 | 4 | |a Drug Approval / United States | |
| 650 | 7 | |a Orphan drugs |2 fast | |
| 650 | 4 | |a Recht | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Reljanović, Miroslav |e Verfasser |4 aut | |
| 830 | 0 | |a Woodhead publishing series in biomedicine |v 46 |w (DE-604)BV040675553 |9 46 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027537054 | ||
Record in the Search Index
| _version_ | 1804152557303496704 |
|---|---|
| any_adam_object | |
| author | Hernberg-Ståhl, Elizabeth Reljanović, Miroslav |
| author_facet | Hernberg-Ståhl, Elizabeth Reljanović, Miroslav |
| author_role | aut aut |
| author_sort | Hernberg-Ståhl, Elizabeth |
| author_variant | e h s ehs m r mr |
| building | Verbundindex |
| bvnumber | BV042096295 |
| ctrlnum | (DE-599)BVBBV042096295 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01352nam a2200385 cb4500</leader><controlfield tag="001">BV042096295</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150210 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">140929s2013 d||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781907568091</subfield><subfield code="9">978-1-907568-09-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1907568093</subfield><subfield code="9">1-907568-09-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042096295</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hernberg-Ståhl, Elizabeth</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Orphan drugs</subfield><subfield code="b">understanding the rare disease market and its dynamics</subfield><subfield code="c">Elizabeth Hernberg-Ståhl and Miroslav Reljanović</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford [u.a.]</subfield><subfield code="b">WP, Woodhead Publ.</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 317 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Woodhead publishing series in biomedicine</subfield><subfield code="v">46</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben und Index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Orphan drugs / Law and legislation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug approval / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Orphan Drug Production / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Orphan drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reljanović, Miroslav</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Woodhead publishing series in biomedicine</subfield><subfield code="v">46</subfield><subfield code="w">(DE-604)BV040675553</subfield><subfield code="9">46</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027537054</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV042096295 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T01:12:36Z |
| institution | BVB |
| isbn | 9781907568091 1907568093 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027537054 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | XVIII, 317 S. graph. Darst. |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | WP, Woodhead Publ. |
| record_format | marc |
| series | Woodhead publishing series in biomedicine |
| series2 | Woodhead publishing series in biomedicine |
| spelling | Hernberg-Ståhl, Elizabeth Verfasser aut Orphan drugs understanding the rare disease market and its dynamics Elizabeth Hernberg-Ståhl and Miroslav Reljanović Oxford [u.a.] WP, Woodhead Publ. 2013 XVIII, 317 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Woodhead publishing series in biomedicine 46 Literaturangaben und Index Orphan drugs / Law and legislation / United States Drug approval / United States Orphan Drug Production / United States Drug Approval / United States Orphan drugs fast Recht USA Reljanović, Miroslav Verfasser aut Woodhead publishing series in biomedicine 46 (DE-604)BV040675553 46 |
| spellingShingle | Hernberg-Ståhl, Elizabeth Reljanović, Miroslav Orphan drugs understanding the rare disease market and its dynamics Woodhead publishing series in biomedicine Orphan drugs / Law and legislation / United States Drug approval / United States Orphan Drug Production / United States Drug Approval / United States Orphan drugs fast Recht |
| title | Orphan drugs understanding the rare disease market and its dynamics |
| title_auth | Orphan drugs understanding the rare disease market and its dynamics |
| title_exact_search | Orphan drugs understanding the rare disease market and its dynamics |
| title_full | Orphan drugs understanding the rare disease market and its dynamics Elizabeth Hernberg-Ståhl and Miroslav Reljanović |
| title_fullStr | Orphan drugs understanding the rare disease market and its dynamics Elizabeth Hernberg-Ståhl and Miroslav Reljanović |
| title_full_unstemmed | Orphan drugs understanding the rare disease market and its dynamics Elizabeth Hernberg-Ståhl and Miroslav Reljanović |
| title_short | Orphan drugs |
| title_sort | orphan drugs understanding the rare disease market and its dynamics |
| title_sub | understanding the rare disease market and its dynamics |
| topic | Orphan drugs / Law and legislation / United States Drug approval / United States Orphan Drug Production / United States Drug Approval / United States Orphan drugs fast Recht |
| topic_facet | Orphan drugs / Law and legislation / United States Drug approval / United States Orphan Drug Production / United States Drug Approval / United States Orphan drugs Recht USA |
| volume_link | (DE-604)BV040675553 |
| work_keys_str_mv | AT hernbergstahlelizabeth orphandrugsunderstandingtherarediseasemarketanditsdynamics AT reljanovicmiroslav orphandrugsunderstandingtherarediseasemarketanditsdynamics |